HotPennyStockNews.com is devoted to fetch you the most exclusive stocks in the market today. Apart from scanning the markets for the most underrated stocks. We propel those victors directly to your email inbox first ahead of the rest of the marketplace gets a prospect.
Los Angelas, CA -- (SBWIRE) -- 10/31/2012 -- VIVUS Inc. (NASDAQ:VVUS) is a biopharmaceutical company commercializing and developing innovative, next-generation therapies to address unmet needs in obesity, sleep apnea, diabetes and sexual health in U.S., Europe and other world markets. Qsymia, which the company intends to market outside of the U.S. under the name Qsiva™, is also in phase 2 clinical development for the treatment of type 2 diabetes and obstructive sleep apnea. VIVUS, Inc. stock dropped 2.06% and closed at $17.55. The company, last week, announced that is has received the formal opinion from the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) following their October 15-18 meeting. As expected, the CHMP recommended against approval of the Marketing Authorization Application (MAA) for Qsiva (phentermine/topiramate ER) for the treatment of obesity in the European Union.
How Should Investors Trade VVUS Now? Find Out Here
GT Advanced Technologies Inc. (NASDAQ:GTAT), formerly GT Solar International, Inc., is a worldwide provider of polysilicon production technology and crystalline ingot growth systems and related photovoltaic manufacturing services to the solar industry, and sapphire growth systems and material for the light emitting diodes (LED) and other specialty markets. GT Advanced Technologies Inc (NASDAQ:GTAT) percentage change is down -13.18% to trade at $4.45 with the traded volume of 8.34 million shares, more than average volume of 3.74 million. Its 52 weeks price change was -37.56%. Its market capitalization is $528.10 million. Its earnings per share was $1.19 with the net profit margin of 16.38% and its operating margin was 25.38%. It gained 47.80% return on equity.
How Should Investors React To GTAT Now? Find Out Here
Netflix, Inc. (NASDAQ:NFLX) is an Internet subscription service streaming television shows and movies. The Company’s subscribers can watch unlimited television shows and movies streamed over the Internet to their televisions, computers and mobile devices, and in the United States, subscribers can also receive digital versatile discs (DVDs) delivered to their homes. Netflix, Inc. (NASDAQ:NFLX) shares are showing a volatile move this morning and recently rose 2.50% to $71.31 after falling 85 in the early session. On Friday, the stock rose 13% on rumors circulating among market participants that the company could be an acquisition target and the interested party could be Microsoft. Let’s see how things will go on with the struggling company, whose shares have slumped over 75% from its lifetime peak.
How Should Investors Trade NFLX After The Recent Volatile Moves? Find Out Here
JDS Uniphase Corp(NASDAQ:JDSU) slipped 4.65% to $9.85 after the Company announced first quarter results. The net loss was $11.6 million or $0.05 per share compared to $5.8 million or $0.03 per share in the prior year quarter. However, analysts expected earnings of $0.12 per share for the first quarter.Net revenue for the quarter increased 1.2% to $420.9 million.Operating margin for the quarter contracted 130 basis points to break even.
Get Free Trend Analysis on To Know More About JDSU Here
Neither HotPennyStockNews.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor or broker dealer in any jurisdiction whatsoever and none of the information provided by HotPennyStockNews.com, owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or an investment recommendation. HotPennyStockNews.com makes no recommendation that the securities of the companies profiled should be purchased, sold or held by individuals or entities that learn of the profiled companies through HotPennyStockNews.com. Investing in securities is speculative and carries a high degree of risk and no investment should be made unless you can afford to lose your entire investment. It is possible that an investor's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein..
Contact Us: 888-4-SBWIRE (US) - 920-321-1250 (International)